By Devika Patel
Knoxville, Tenn., Jan. 4 - Osteologix, Inc. arranged a $1 million private placement of stock on Dec. 29, according to an 8-K filed Monday with the Securities and Exchange Commission.
The company will sell 1,992,448 common shares at approximately $0.5019 per share to Nordic Biotech Opportunity Fund K/S.
Settlement is expected Jan. 7.
San Francisco-based Osteologix develops treatments for bone disease and women's health issues.
| Issuer: | Osteologix, Inc.
|
| Issue: | Common stock
|
| Amount: | $1 million
|
| Shares: | 1,992,448
|
| Price: | $0.5019 (approximate)
|
| Warrants: | No
|
| Investor: | Nordic Biotech Opportunity Fund K/S
|
| Pricing date: | Dec. 29
|
| Settlement date: | Jan. 7
|
| Stock symbol: | OTCBB: OLGX
|
| Stock price: | $0.49 at close Dec. 29
|
| Market capitalization: | $15 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
